These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24362313)

  • 1. Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma.
    Bethge N; Lothe RA; Honne H; Andresen K; Trøen G; Eknæs M; Liestøl K; Holte H; Delabie J; Smeland EB; Lind GE
    Epigenetics; 2014 Mar; 9(3):428-36. PubMed ID: 24362313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
    Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
    Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening and diagnostic value of the molecular markers of DNA methylation in colorectal neoplasma].
    Ma J; Yang Q; Deng C; Jin H; Gong W; Wang S; Chen H; Fan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1149-53. PubMed ID: 26616813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.
    Lind GE; Danielsen SA; Ahlquist T; Merok MA; Andresen K; Skotheim RI; Hektoen M; Rognum TO; Meling GI; Hoff G; Bretthauer M; Thiis-Evensen E; Nesbakken A; Lothe RA
    Mol Cancer; 2011 Jul; 10():85. PubMed ID: 21777459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.
    Vedeld HM; Andresen K; Eilertsen IA; Nesbakken A; Seruca R; Gladhaug IP; Thiis-Evensen E; Rognum TO; Boberg KM; Lind GE
    Int J Cancer; 2015 Feb; 136(4):844-53. PubMed ID: 24948044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis.
    Lind GE; Raiborg C; Danielsen SA; Rognum TO; Thiis-Evensen E; Hoff G; Nesbakken A; Stenmark H; Lothe RA
    Oncogene; 2011 Sep; 30(37):3967-78. PubMed ID: 21499309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer.
    Li WH; Zhang H; Guo Q; Wu XD; Xu ZS; Dang CX; Xia P; Song YC
    Dis Markers; 2015; 2015():657570. PubMed ID: 25802477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma.
    Andresen K; Boberg KM; Vedeld HM; Honne H; Jebsen P; Hektoen M; Wadsworth CA; Clausen OP; Lundin KE; Paulsen V; Foss A; Mathisen Ø; Aabakken L; Schrumpf E; Lothe RA; Lind GE
    Hepatology; 2015 May; 61(5):1651-9. PubMed ID: 25644509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells.
    Frazzi R; Cusenza VY; Pistoni M; Canovi L; Cascione L; Bertoni F; Merli F
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34751409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Silencing of Tumor Suppressor lncRNA
    Zhang MY; Calin G; Deng MD; Au-Yeung RKH; Wang LQ; Chim CS
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
    Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
    J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
    Eberth S; Schneider B; Rosenwald A; Hartmann EM; Romani J; Zaborski M; Siebert R; Drexler HG; Quentmeier H
    BMC Cancer; 2010 Sep; 10():517. PubMed ID: 20920234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylomics analysis identifies a putative STAT3 target, SPG20, as a noninvasive epigenetic biomarker for early detection of gastric cancer.
    Wei KL; Chou JL; Chen YC; Jin H; Chuang YM; Wu CS; Chan MWY
    PLoS One; 2019; 14(6):e0218338. PubMed ID: 31194837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
    Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
    BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene panel, including LRP12, is frequently hypermethylated in major types of B-cell lymphoma.
    Bethge N; Honne H; Andresen K; Hilden V; Trøen G; Liestøl K; Holte H; Delabie J; Lind GE; Smeland EB
    PLoS One; 2014; 9(9):e104249. PubMed ID: 25226156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
    Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
    Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of highly methylated genes across various types of B-cell non-hodgkin lymphoma.
    Bethge N; Honne H; Hilden V; Trøen G; Eknæs M; Liestøl K; Holte H; Delabie J; Smeland EB; Lind GE
    PLoS One; 2013; 8(11):e79602. PubMed ID: 24260260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
    Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
    Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-assessing
    Vedeld HM; Nesbakken A; Lothe RA; Lind GE
    Clin Epigenetics; 2018; 10():70. PubMed ID: 29854011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
    Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
    Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.